MedPage Today

Menopausal Status and Hormones Impact Bladder Health

—A recent study suggests that perimenopausal and postmenopausal women report worse bladder health and function compared to their premenopausal counterparts. Additionally, current hormone use was ...
Cure Today

Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer

Bavencio shows efficacy and safety in advanced urothelial carcinoma, regardless of diabetes status, as per JAVELIN Bladder 100 trial findings. Diabetes requires careful management in patients ...
CURE

Induction Yervoy and Opdivo May Support Bladder Preservation

Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...
MedPage Today on MSN

Organ-Sparing Strategy 'Promising' in Muscle-Invasive Bladder Cancer

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...
Nasdaq

Relmada Therapeutics Reports Promising Phase 2 Data for NDV-01 in Non-Muscle Invasive Bladder Cancer with 90% of Patients Achieving Disease-Free Status

100% (n=7) of evaluable patients (1 CIS, 6 Ta/T1) achieved disease free status. One of these patients was re-treated at 3 months. “I am impressed by these promising NDV-01 data reported at AUA2025.
Business Wire

14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of ...